1.87 Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company

<< vissza

Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company
Dátum: 2024-04-12 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>
×